Citations

Showing 10 of 108083 citations.

Unexpected sequences and structures of mtDNA required for efficient transcription from the first heavy-strand promoter
Uchida, Akira , Murugesapillai, Divakaran , Kastner, Markus , Lodeiro, María F. , Prabhakar, Shaan, Oliver, Guinevere V , Arnold, Jamie J. , Maher, L. James, Williams, Mark C. , Cameron, Craig E. , Oliver, Guinevere V , Arnold, Jamie J , Williams, Mark C , Cameron, Craig E , Wang, Yao

Mayo Clinic

eLife | July 26, 2017 | Volume: 6 | Issue: No issue available | Pages: No page available

10.7554/elife.27283 | PMID 28745586 Get It

Human mtDNA contains three promoters, suggesting a need for differential expression of the mitochondrial genome. Studies of mitochondrial transcription have used a reductionist approach, perhaps masking differential regulation. Here we evaluate transcription from light-strand (LSP) and heavy-strand (HSP1) promoters using templates that mimic their natural context. These studies reveal sequences upstream, hypervariable in the human population (HVR3), and downstream of the HSP1 transcription start site required for maximal yield. The carboxy-terminal tail of TFAM is essential for activation of HSP1 but not LSP. Images of the template obtained by atomic force microscopy show that TFAM creates loops in a discrete region, the formation of which correlates with activation of HSP1; looping is lost in tail-deleted TFAM. Identification of HVR3 as a transcriptional regulatory element may contribute to between-individual variability in mitochondrial gene expression. The unique requirement of HSP1 for the TFAM tail may enable its regulation by post-translational modifications.
Prognosis of Patients with Behavioral Variant Frontotemporal Dementia Who have Focal Versus Diffuse Frontal Atrophy
Lee, Jin San , Jang, Young Kyoung, Kim, Hee Jin, Seo, Sang Won , Lee, Juyoun , Kim, Yeo Jin , Park, Kyung-Won, Yoon, Soo Jin , Kim, Seung Hyun , Park, Key‐Chung , Knopman, David S. , Na, Duk L. , Jung, Na‐Yeon , Kim, Hee Jin, Lee, Jae‐Hong , Kim, Byeong Chae , Yoon, Soo Jin , Kim, SangYun , Kim, Eun‐Joo , Knopman, David S.

Mayo Clinic

Journal of Clinical Neurology | July 26, 2017 | Volume: 13 | Issue: 3 | Pages: 234

10.3988/jcn.2017.13.3.234 | PMID 28748674 Get It

Pulmonary Pressure Assessment with the Total Artificial Heart
Joyce, David L. , Redfield, Margaret M. , Kushwaha, Sudhir S. , Behfar, Atta , Borlaug, Barry A. , Daly, Richard C. , Sandhu, Gurpreet S. , Joyce, Lyle D., Behfar, Atta , Borlaug, Barry A

Mayo Clinic

ASAIO Journal | July 25, 2017 | Volume: 64 | Issue: 3 | Pages: e34-e36

10.1097/mat.0000000000000632 | PMID 28742532 Get It

Reversal of pulmonary hypertension has been observed in patients during a bridge to transplant with a left ventricular assist device. Total artificial heart (TAH) implant prevents subsequent right heart catheterization. Consequently, controversy exists over whether the prosthetic right ventricle improves or exacerbates pulmonary hypertension. A pulmonary artery (PA) pressure monitor was placed in two patients undergoing TAH implant, as a bridge to transplant. One patient had pulmonary hypertension at implant; the other had normal pulmonary pressures. Daily measurements were taken of systolic, diastolic, and mean PA pressures throughout support. Patient 1 received successful transplant after TAH support of 91 days. Systolic/diastolic (mean) PA pressures steadily decreased from 55/39 (28) mm Hg at implant to 29/18 (7) mm Hg currently. Patient 2 received support for 101 days before death due to abdominal ischemic complications. Pulmonary arterial pressures stayed consistent throughout this period, from 26/17 (20) mm Hg at implant to 23/13 (17) mm Hg at the time of death. These findings suggest that an implantable PA pressure monitor may be useful in optimizing hemodynamics and planning appropriate timing of transplant with TAH support.
Chemoimmunotherapy Is Not Dead Yet in Chronic Lymphocytic Leukemia
Brown, Jennifer R. , Kay, Neil E.

Mayo Clinic

Journal of Clinical Oncology | July 25, 2017 | Volume: 35 | Issue: 26 | Pages: 2989-2992

10.1200/jco.2017.72.6810 | PMID 28742455 Get It

Anterior Extension of Tumor is as Important as Tumor Size to Facial Nerve Outcome and Extent of Resection for Vestibular Schwannomas
Wong, Ricky H. , Jacob, Jeffrey T. , Sivakanthan, Sananthan , Loveren, Harry van , Link, Michael J. , Copeland, William , Gompel, Jamie J. Van , Agazzi, Siviero

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | July 25, 2017 | Volume: 78 | Issue: 06 | Pages: 473-480

10.1055/s-0037-1604331 | PMID 29134166 Get It

Objectives We examined vestibular schwannoma tumor dimension and direction of growth to determine whether these correlate with facial nerve outcome as well as extent of resection (EOR). Design Retrospective review of prospectively maintained databases. Participants 206 patients were a part of this study. Main Outcome Measures Tumor dimensions were measured using preoperative magnetic resonance imaging, and a series of ratios were then calculated to further characterize tumor dimension. Regression analyses were performed to investigate correlation with facial nerve outcome and EOR. Results Patients with tumor extending >1.5 cm anterior to the internal auditory canal (IAC) (AB measurement) were three times more likely to have postoperative House-Brackman grades of 3 or worse. We also found that an EB/BF ratio (representing elongated growth parallel to the IAC axis) ≥1.1 was associated with half the risk of poor facial nerve outcome. Tumors with anterior-posterior diameter (AC measurement) >1.9 cm were five times less likely to undergo gross total resection (GTR). Furthermore, an increased degree of tumor extension into the IAC (DE measurement >2.4 cm) or an increased amount of brainstem compression (EB measurement >1.1 cm) were each associated with a nearly 3-fold decrease in the likelihood of GTR. Conclusion Our study demonstrates that anterior extent of the tumor is as important as tumor size to facial nerve outcome and degree of resection for vestibular schwannomas.
Reply
Birmingham, Dan, Cartin‐Ceba, Rodrigo , Stone, John H., Rovin, Brad H. , Specks, Ulrich

Mayo Clinic

Arthritis & Rheumatology | July 25, 2017 | Volume: 69 | Issue: 11 | Pages: 2247-2248

10.1002/art.40220 | PMID 28743161 Get It

Fracture of the Ankylosed Spine Following a Direct Anterior Approach for Total Hip Arthroplasty on a Fracture Table
Petis, Stephen M. , Taunton, Michael J. , Petis, Stephen , Taunton, Michael J

Mayo Clinic

JBJS Case Connector | July 25, 2017 | Volume: 7 | Issue: 3 | Pages: e51-e51

10.2106/jbjs.cc.17.00017 | PMID 29252881 Get It

Case: An 85-year-old man with diffuse idiopathic skeletal hyperostosis underwent total hip arthroplasty (THA) through a direct anterior approach. Postoperatively, persistent blood loss and worsening abdominal and back pain prompted computed tomography, which identified an L1 hyperextension fracture-dislocation. The patient underwent staged posterior and anterior instrumented fusion. At the 5-year follow-up, he had persistent dorsal column dysfunction. Conclusion: Fracture-dislocation of the ankylosed spine is a rare complication following THA. We recommend lateral decubitus positioning, pelvic and back support, careful limb manipulation, and an in situ femoral neck osteotomy to avoid excessive loads on the stiff spine during THA.
Left Ventricular Septal Hypertrophy in Elderly Patients With Aortic Stenosis
Katayama, Minako , Panse, Prasad M., Kendall, Christopher B., Daniels, John R., Cha, Stephen S., Fortuin, F. David , Sweeney, John P., DeValeria, Patrick A. , Lanza, Louis A., Bëlohlávek, Marek , Chaliki, Hari P. , Cha, Stephen S.

Mayo Clinic

Journal of Ultrasound in Medicine | July 25, 2017 | Volume: 37 | Issue: 1 | Pages: 217-224

10.1002/jum.14320 | PMID 28741721 Get It

ObjectivesLeft ventricular (LV) septal hypertrophy in aortic stenosis raises diagnostic and therapeutic questions. However, the etiology and clinical consequences of this finding have not been well studied. The aim of this study was to perform a morphologic evaluation of the LV in aortic stenosis and to investigate the contributing factors and consequences of septal hypertrophy.MethodsPatients with moderate or severe aortic stenosis were prospectively enrolled. Patients with previous myocardial infarction, wall motion abnormalities, at least moderate valvular regurgitation, known cardiomyopathy, an LV ejection fraction of less than 50%, and age younger than 65 years were excluded.ResultsForty‐one patients underwent a final analysis. Septal hypertrophy (LV septal wall thickness ≥15 mm) was confirmed in 21 of 41 patients. The septal hypertrophy group had higher peak aortic valve velocity, a higher diabetes mellitus rate, and a higher rate and longer duration of hypertension than those without septal hypertrophy. The peak aortic valve velocity (odds ratio, 7.1; 95% confidence interval, 1.4–37.1) and diabetes mellitus (odds ratio, 7.4; 95% confidence interval, 1.2–46.2) were the significant factors associated with septal hypertrophy by multivariate analysis. Intraventricular conduction disturbance on electrocardiography was more frequent in the septal hypertrophy group (P = .021).ConclusionsLeft ventricular septal hypertrophy was commonly observed in elderly patients with aortic stenosis, and a higher aortic valve velocity, hypertension, and diabetes mellitus were associated factors. Intraventricular conduction disturbance occurred more often in patients with septal hypertrophy than those without, which implies the pathophysiologic consequence. Further studies are needed to determine the impact of septal hypertrophy and intraventricular conduction disturbance on the prognosis of patients after aortic valve interventions.
Development of quality metrics for ambulatory pediatric cardiology: Infection prevention
Johnson, Jonathan N. , Barrett, Cindy, Franklin, Wayne H., Graham, Eric M. , Halnon, Nancy , Hattendorf, Brandy, Krawczeski, Catherine D. , McGovern, James J., Vinocur, Jeffrey M. , Chowdhury, Devyani , Anderson, Jeffrey , O’Connor, Matthew J. , Schultz, Amy , Vinocur, Jeffrey M

Mayo Clinic

Congenital Heart Disease | July 25, 2017 | Volume: 12 | Issue: 6 | Pages: 756-761

10.1111/chd.12519 | PMID 28741863 Get It

Finding a Balance between Protection and Pathology: The Dual Role of Perforin in Human Disease
Willenbring, Robin, Johnson, Aaron J. , Orozco, Robin C. , Willenbring, Robin C, Johnson, Aaron J. , Willenbring, Robin C

Mayo Clinic

International Journal of Molecular Sciences | July 25, 2017 | Volume: 18 | Issue: 8 | Pages: 1608

10.3390/ijms18081608 | PMID 28757574 Get It

Perforin is critical for controlling viral infection and tumor surveillance. Clinically, mutations in perforin are viewed as unfavorable, as lack of this pore-forming protein results in lethal, childhood disease, familial hemophagocytic lymphohistiocytosis type 2 (FHL 2). However, many mutations in the coding region of PRF1 are not yet associated with disease. Animal models of viral-associated blood–brain barrier (BBB) disruption and experimental cerebral malaria (ECM) have identified perforin as critical for inducing pathologic central nervous system CNS vascular permeability. This review focuses on the role of perforin in both protecting and promoting human disease. It concludes with a novel hypothesis that diversity observed in the PRF1 gene may be an example of selective advantage that protects an individual from perforin-mediated pathology, such as BBB disruption.